Star Combo Pharma Ltd - Asset Resilience Ratio
Star Combo Pharma Ltd (S66) has an Asset Resilience Ratio of 67.35% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read S66 liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how Star Combo Pharma Ltd's Asset Resilience Ratio has changed over time. See S66 net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Star Combo Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see S66 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$18.11 Million | 37.38% |
| Short-term Investments | AU$14.52 Million | 29.97% |
| Total Liquid Assets | AU$32.63 Million | 67.35% |
Asset Resilience Insights
- Very High Liquidity: Star Combo Pharma Ltd maintains exceptional liquid asset reserves at 67.35% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Star Combo Pharma Ltd Industry Peers by Asset Resilience Ratio
Compare Star Combo Pharma Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Chongqing Baiya Sanitary Products Co
SHE:003006 |
Household & Personal Products | 9.52% |
|
Fujian Green Pine Co Ltd
SHE:300132 |
Household & Personal Products | 2.72% |
|
Chungdamglobal Co. Ltd.
KQ:362320 |
Household & Personal Products | 16.00% |
|
Rigolleau SA
BA:RIGO |
Household & Personal Products | 0.27% |
|
Anagenics Ltd
AU:AN1 |
Household & Personal Products | 7.19% |
|
ZOONO Group Ltd
AU:ZNO |
Household & Personal Products | 0.87% |
|
Mcphersons Ltd
AU:MCP |
Household & Personal Products | 8.08% |
|
Skin Elements Ltd
AU:SKN |
Household & Personal Products | 21.26% |
Annual Asset Resilience Ratio for Star Combo Pharma Ltd (2019–2025)
The table below shows the annual Asset Resilience Ratio data for Star Combo Pharma Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 29.97% | AU$14.52 Million ≈ $10.27 Million |
AU$48.45 Million ≈ $34.28 Million |
+17.84pp |
| 2024-06-30 | 12.13% | AU$5.20 Million ≈ $3.68 Million |
AU$42.82 Million ≈ $30.29 Million |
-18.65pp |
| 2023-06-30 | 30.79% | AU$13.00 Million ≈ $9.20 Million |
AU$42.23 Million ≈ $29.88 Million |
+3.16pp |
| 2022-06-30 | 27.62% | AU$12.00 Million ≈ $8.49 Million |
AU$43.44 Million ≈ $30.74 Million |
-23.44pp |
| 2021-06-30 | 51.06% | AU$22.12 Million ≈ $15.65 Million |
AU$43.32 Million ≈ $30.65 Million |
+14.51pp |
| 2020-06-30 | 36.55% | AU$20.00 Million ≈ $14.15 Million |
AU$54.72 Million ≈ $38.72 Million |
+32.91pp |
| 2019-06-30 | 3.64% | AU$1.00 Million ≈ $709.00K |
AU$27.51 Million ≈ $19.46 Million |
-- |
About Star Combo Pharma Ltd
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its pro… Read more